XM2UG5

ICD-11 MMS 2026-01

Neuromuscular blocking drug

Index terms

  • Neuromuscular blocking drug

Sibling codes

  • XM3676 – Laudexium
  • XM3RJ7 – Methocarbamol skeletal muscle relaxant
  • XM3SC6 – Myoneural blocking agents
  • XM3V06 – Aclatonium napadisilate
  • XM4W78 – Muscle affecting agents relaxants skeletal
  • XM5GC4 – Atracurium besilate
  • XM5ZN8 – Dantrolene
  • XM6XS1 – Dimethyltubocurarinium chloride
  • XM7142 – Suxethonium chloride
  • XM7DG2 – Decamethonium bromide
  • XM82Z5 – Hexcarbacholine bromide
  • XM8A87 – Flaxedil
  • XM8PU1 – Carbolonium (bromide)
  • XM8QC2 – Skeletal muscle relaxants
  • XM8SY4 – Muscle relaxants, peripherally acting
  • XM91M0 – Spasmolytic skeletal muscle
  • XM9502 – Woorali
  • XM9QC2 – Hexafluorenium bromide
  • XM9RW1 – Anesthesia muscle relaxation
  • XM9WH2 – Hexanuorenium
  • XM9YY8 – Muscle relaxants, centrally acting

Foundation entity

Neuromuscular blocking drug – http://id.who.int/icd/entity/189038805

Part of: XM1950: Agents primarily acting on smooth and skeletal muscles or the respiratory system › XM6S30: Medicaments › X: Extension Codes